Trial intelligence / Profile preview

Collagenase Injection for Flexor Tendon Adhesions

NCT00261209Phase 2Completed

Sponsor
Stony Brook University
Start
Jan 2005
Primary completion
Jan 2008
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 2 trial of collagenase clostridium histolyticum in flexor tendon adhesion, sponsored by Stony Brook University. Started Jan 2005; status: completed.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

flexor tendon adhesion

Beyond the preview

Go deeper on NCT00261209.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00261209.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call